MedTrace Logo

Effect of Macronutrients on Post-Exercise Glycemic Response in Males With Type 2 Diabetes

NCT07175740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-09-16

No results posted yet for this study

Summary

The goal of this randomized crossover trial is to evaluate the impact of meal macronutrient composition on the glycemic response following exercise in males with type 2 diabetes. The main question it aims to answer is:

• Is the consumption of a glucose enriched meal associated with a bigger reduction in plasma glucose following a 1-hour exercise session than other meals Researchers will compare different meal macronutrient composition to see how it affects the glycemic response after exercise.

Participants will

* Fast, then do a 1-hour exercise session
* Eat a glucose enriched meal, then do a 1-hour exercise session
* Eat a fructose enriched meal, then do a 1-hour exercise session
* Eat a fat enriched meal, then do a 1-hour exercise session
* Eat an aspartame enriched meal, then do a 1-hour exercise session

Conditions

Interventions

DIETARY_SUPPLEMENT

Fasting

No meal

DIETARY_SUPPLEMENT

Sucrose enriched meal

175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 22g sucrose

DIETARY_SUPPLEMENT

Fructose enriched meal

175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 22g fructose

DIETARY_SUPPLEMENT

Fat enriched meal

175 ml of oatmeal cereal, one slice of bread, 30g of cheese, 15g fat

DIETARY_SUPPLEMENT

Aspartame enriched meal

175 ml of oatmeal cereal, one slice of bread, 30g of cheese, aspartame (matched for taste)

OTHER

Exercise session

A 60-minutes exercise session on a cycle ergometer (Corival 400, Quinton Instruments, Seattle, WA, USA) at 60% of the VO2peak (determined at a baseline visit)

Sponsors & Collaborators

  • Paul Poirier

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-30
Primary Completion
2004-05-28
Completion
2004-05-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07175740 on ClinicalTrials.gov